Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
- 30 September 2012
- journal article
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 18 (8), 941-947
- https://doi.org/10.1016/j.parkreldis.2012.04.028
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriersNeurology, 2012
- CSF amyloid β 1-42 predicts cognitive decline in Parkinson diseaseNeurology, 2010
- CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentMovement Disorders, 2010
- Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI studyNeurobiology of Aging, 2010
- Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive DeclineJournal of Neuroscience, 2010
- Use of cerebrospinal fluid biomarkers in diagnosis of dementia across EuropeEuropean Journal of Neurology, 2009
- Ten simple rules for reporting voxel-based morphometry studiesNeuroImage, 2008
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometryJournal of Neurology, Neurosurgery & Psychiatry, 2006
- ParkinsonismNeurology, 1967